![Elizabeth Garofalo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Garofalo
Directeur/Membre du Conseil chez
ACADIA PHARMACEUTICALS INC.
Fortune : 1 M $ au 31/05/2026
Profil
Elizabeth A Garofalo currently serves as Independent Director at ACADIA Pharmaceuticals, Inc. since 2020, Independent Director at Xenon Pharmaceuticals, Inc. since 2021, Independent Director at Alector, Inc. since 2021, Director at the Institute For Advanced Clinical Trials For Children, and Principal at EAG Pharma Consulting LLC since 2016.
Former roles include Chairman at Exicure, Inc. from 2022 to 2023, Head-Neuroscience & Worldwide Regulatory Affairs at Pfizer Inc., Global Head-Clinical Development & Senior VP at Novartis International AG, and VP & Head-Neuroscience Therapy Area at Astellas Pharma Global Development, Inc. Education includes undergraduate studies at Purdue University and a doctorate from The Indiana University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/05/2026 | 33 489 ( 0,02 % ) | 725 372 $ | 31/05/2026 | |
ALECTOR, INC. 0,06 % | 31/03/2026 | 70 709 ( 0,06 % ) | 152 731 $ | 31/05/2026 |
| 03/06/2026 | 2 645 ( 0 % ) | 144 761 $ | 31/05/2026 |
Postes actifs de Elizabeth Garofalo
| Sociétés | Poste | Début |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 29/09/2020 |
| XENON PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 03/06/2021 |
| ALECTOR, INC. | Directeur/Membre du Conseil | 28/09/2021 |
EAG Pharma Consulting LLC | Corporate Officer/Principal | 01/01/2016 |
Institute For Advanced Clinical Trials For Children
 Institute For Advanced Clinical Trials For Children Miscellaneous Commercial ServicesCommercial Services The Institute For Advanced Clinical Trials For Children was a nonprofit organization dedicated to improving pediatric drug development by providing resources and support for efficient, effective pediatric clinical trials. The private company is based in Rockville. It collaborated with strategic partners including major children’s hospitals and universities, offered educational webinars, and published research on pediatric clinical trial methodologies and regulatory topics. The American company was founded by Caroline D. Dorsa. Alexandre P. LeBeaut has been the CEO of the company since 2021. | Directeur/Membre du Conseil | - |
Anciens postes connus de Elizabeth Garofalo
| Sociétés | Poste | Fin |
|---|---|---|
| EXICURE, INC. | Président | 24/02/2023 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | - |
Formation de Elizabeth Garofalo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
The Indiana University School of Medicine
 The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure, Inc.
 Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
Institute For Advanced Clinical Trials For Children
Institute For Advanced Clinical Trials For Children Miscellaneous Commercial ServicesCommercial Services The Institute For Advanced Clinical Trials For Children was a nonprofit organization dedicated to improving pediatric drug development by providing resources and support for efficient, effective pediatric clinical trials. The private company is based in Rockville. It collaborated with strategic partners including major children’s hospitals and universities, offered educational webinars, and published research on pediatric clinical trial methodologies and regulatory topics. The American company was founded by Caroline D. Dorsa. Alexandre P. LeBeaut has been the CEO of the company since 2021. | Commercial Services |
EAG Pharma Consulting LLC |
